Background and Aim: Squamous cell carcinoma antigen (SCCA) is a serine protease inhibitor that can be overexpressed in hepatocellular carcinoma (HCC) at both molecular and protein level, but no data are available on its expression in pre-malignant stages. The aim of this study was to assess SCCA expression by immunohistochemistry in HCC and its nodular precursors in cirrhotic livers. Methods: Fifty-five nodules from 42 explanted livers were evaluated, including 7 large-regenerative nodules (LRNs), 7 low-grade dysplastic nodules (lg-DNs), 10 high-grade DNs (hg-DNs), and 31 HCC. SCCA expression was semiquantitatively scored in a four-tiered scale. Results: SCCA hepatocyte immunostaining was always restricted to the cytoplasm, mainly exhibiting a granular pattern. Stain intensity varied, ranging from weak to very strong. Within the nodules, positive cells were unevenly distributed, either scattered or in irregular clusters. The prevalence of SCCA expression was 29% in LRNs, 100% in DNs and 93% in HCC. A significant difference emerged in both prevalence and score for LRNs versus LG-DNs (p=0.039), HG-DNs (p=0.001), and HCC (p=0.000). A barely significant difference (p= 0.49) was observed between LG- and HG-DNs, while no difference in SCCA expression was detected between HG-DNs and HCCs (p=n.s.). Cirrhotic tissue adjacent to the nodules was positive in 96% of cases, with a significant difference in the score (p=0.000) between hepatocytes adjacent to HCC and those surrounding LRNs. Conclusion: This study provides the first evidence that aberrant SCCA expression is an early event in liver cell carcinomatous transformation.
- dysplastic nodules
- hepatocellular carcinoma
- pre-neoplastic liver lesions
- squamous cell carcinoma antigen
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.